Global Blood Therapeutics' Acquisition Value Could Be At Least $3 Billion
March 20, 2017 at 09:30 AM EDT
Global Blood Therapeutics Inc (NASDAQ: GBT) is in the process of developing GBT440 to reduce the severity and frequency of crises and ...